Member access

4-Traders Homepage  >  Shares  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

MORPHOSYS AG (MOR)

27
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
10/14/2014 10/15/2014 10/16/2014 10/17/2014 10/20/2014 Date
66.82(c) 65.36(c) 64.73(c) 68.01(c) 68.23 Last
169 373 171 741 236 611 182 302 214 953 Volume
-0.86% -2.18% -0.96% +5.07% +0.32% Change
More quotes
Company
MorphoSys AG is engaged in the development of antibodies for therapeutic, diagnostic, and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development, and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
Surperformance© rating of MorphoSys AG
Trading Rating : Investor Rating :
More about the company
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 62,6 M
EBIT 2014 -14,2 M
Net income 2014 -13,4 M
Finance 2014 275 M
Yield 2014 -
Sales 2015 71,1 M
EBIT 2015 -0,23 M
Net income 2015 -8,23 M
Finance 2015 261 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 24,3x
EV / Sales 2015 21,6x
Capitalization 1 794 M
More Financials
Latest news on MORPHOSYS AG
17h ago MORPHOSYS : Announces Clinical Milestone in Ophthalmology Program
17h ago MORPHOSYS : Announces Clinical Milestone in Ophthalmology Program
5d ago MorphoSys Acquires Lanthipeptide Technology from Lanthio Pharma
5d ago MORPHOSYS : Acquires Lanthipeptide Technology from Lanthio Pharma
5d ago MORPHOSYS : Acquires Lanthipeptide Technology from Lanthio Pharma
09/15 MORPHOSYS : Receives Research Grant to Develop Novel Therapeutic Antibodies Targ..
09/15 MORPHOSYS : Receives Research Grant to Develop Novel Therapeutic Antibodies Targ..
09/04 MORPHOSYS : to Present at Six Investor Conferences in September
08/27 EMERGENT BIOSOLUTIONS : and MorphoSys Sign License Agreement to Co-Develop and C..
08/20 MORPHOSYS : and Emergent BioSolutions Sign License Agreement to Co-Develop and C..
08/20 MORPHOSYS : to Host Conference Call on License Agreement with Emergent to Co-Dev..
08/19 EMERGENT BIOSOLUTIONS : MorphoSys and Emergent BioSolutions Sign License Agreeme..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF